| Atritech News | |
|
Favorable Clinical Study Results Reported with Dual Antiplatelet Therapy after LAA Closure with WATCHMAN Device Boston Scientific to Acquire Atritech Atritech Enrolls First Patient into PREVAIL Study Atritech announces German Reimbursement coverage Atritech announces FDA Regulatory Update Atritech completes $30 million financing Atritech to participate in late breaking clinical trial presentation at American College of Cardiology meeting Atritech files pre-market approval application for its WATCHMAN® LAA Closure Technology Atritech announces completion of a $22 million equity financing Atritech announces acquisition of IP |